BON - Bon Natural Life Ltd


1.46
0   0%

Share volume: 20,513
Last Updated: 03-06-2026
Pharmaceutical Products/Medicinal Chemicals: 2.19%

PREVIOUS CLOSE
CHG
CHG%

$1.46
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
-9.88%
1 Month
-8.75%
3 Months
-20.65%
6 Months
-5.19%
1 Year
1.39%
2 Year
1.39%
Key data
Stock price
$1.46
P/E Ratio 
N/A
DAY RANGE
$1.41 - $1.54
EPS 
N/A
52 WEEK RANGE
$0.05 - $3.40
52 WEEK CHANGE
$1.39
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$31,836
AVERAGE 30 VOLUME 
$146,817
Company detail
CEO: Yong W. Hu
Region: US
Website: bnlus.com
Employees: 100
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Bon Natural Life Limited engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers.

Recent news